• LAST PRICE
    5.3350
  • TODAY'S CHANGE (%)
    Trending Up0.1350 (2.5962%)
  • Bid / Lots
    5.3300/ 12
  • Ask / Lots
    5.3400/ 14
  • Open / Previous Close
    5.2800 / 5.2000
  • Day Range
    Low 5.2700
    High 5.6850
  • 52 Week Range
    Low 4.9100
    High 11.9100
  • Volume
    1,224,225
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 5.2
TimeVolumeEDIT
09:32 ET344545.33
09:34 ET16125.33
09:36 ET231635.45
09:38 ET167595.42
09:39 ET107565.47
09:41 ET161535.5
09:43 ET65165.4565
09:45 ET66325.47
09:48 ET106465.4929
09:50 ET273385.57
09:52 ET203015.52
09:54 ET75755.5
09:56 ET65715.57
09:57 ET208955.58
09:59 ET105895.59
10:01 ET68225.6227
10:03 ET77595.6553
10:06 ET120165.66
10:08 ET1001715.635
10:10 ET101505.59
10:12 ET106715.58
10:14 ET120415.61
10:15 ET123035.62
10:17 ET137065.6
10:19 ET83005.625
10:21 ET65265.6004
10:24 ET157765.6099
10:26 ET104105.59
10:28 ET29185.6
10:30 ET21005.575
10:32 ET69645.616
10:33 ET57215.6
10:35 ET41675.585
10:37 ET14005.595
10:39 ET50195.585
10:42 ET34315.605
10:44 ET74885.605
10:46 ET194215.655
10:48 ET102075.605
10:50 ET29175.615
10:51 ET85105.575
10:53 ET158415.55
10:55 ET31005.555
10:57 ET90275.57
11:00 ET23005.5793
11:02 ET102395.6
11:04 ET2005.59
11:06 ET58455.6001
11:08 ET58685.6252
11:09 ET121255.6399
11:11 ET89475.65
11:13 ET55295.66
11:15 ET67125.64
11:18 ET28255.62
11:20 ET30045.64
11:22 ET35345.6
11:24 ET29705.6
11:26 ET30965.57
11:27 ET22965.6
11:29 ET32685.575
11:31 ET32475.535
11:33 ET15195.53
11:36 ET32665.5115
11:38 ET9855.515
11:40 ET32635.49
11:42 ET42345.46
11:44 ET27825.45
11:45 ET17035.4644
11:47 ET79075.4693
11:49 ET45595.445
11:51 ET55905.43
11:54 ET22005.42
11:56 ET69505.42
11:58 ET23005.42
12:00 ET33565.39
12:02 ET66055.415
12:03 ET6075.4193
12:05 ET14505.42
12:07 ET6005.405
12:09 ET99125.375
12:12 ET69905.395
12:14 ET134405.39
12:16 ET30655.4001
12:18 ET10105.39
12:20 ET14465.405
12:21 ET19365.41
12:23 ET19125.39
12:25 ET5005.4
12:27 ET4005.405
12:30 ET49045.405
12:32 ET91905.39
12:34 ET11405.395
12:36 ET24975.3899
12:38 ET12105.395
12:39 ET40705.415
12:41 ET43075.4
12:43 ET23625.395
12:45 ET35405.38
12:48 ET19005.395
12:50 ET24305.39
12:52 ET6005.395
12:54 ET47045.36
12:56 ET37955.38
12:57 ET28165.37
12:59 ET16015.38
01:01 ET14415.375
01:03 ET2005.375
01:06 ET80995.35
01:08 ET23505.36
01:10 ET30305.36
01:12 ET7905.34
01:14 ET14325.35
01:15 ET10835.35
01:17 ET28005.365
01:19 ET7005.37
01:21 ET6005.38
01:24 ET49805.365
01:26 ET37355.355
01:28 ET23385.355
01:30 ET25005.37
01:32 ET31655.37
01:33 ET28475.37
01:35 ET23215.355
01:37 ET12005.35
01:39 ET9005.35
01:42 ET42135.3425
01:44 ET55265.365
01:46 ET37595.39
01:48 ET27485.3901
01:50 ET9885.395
01:51 ET67685.38
01:53 ET29605.355
01:55 ET35825.35
01:57 ET28145.356
02:00 ET29595.3599
02:02 ET19005.355
02:04 ET55605.355
02:06 ET12505.355
02:08 ET1005.3525
02:09 ET38525.365
02:11 ET12005.37
02:13 ET38385.36
02:15 ET5005.355
02:18 ET4005.36
02:20 ET122995.34
02:22 ET78725.365
02:24 ET2005.365
02:26 ET43585.35
02:27 ET13635.35
02:29 ET6405.345
02:31 ET38595.36
02:33 ET12335.37
02:36 ET39185.35
02:38 ET1005.34
02:40 ET2005.3425
02:42 ET49595.36
02:44 ET28145.34
02:45 ET30505.345
02:47 ET56315.345
02:49 ET17605.345
02:51 ET57755.335
02:54 ET58985.33
02:56 ET26285.33
02:58 ET19355.34
03:00 ET2005.335
03:02 ET66255.315
03:03 ET10905.315
03:05 ET60115.3
03:07 ET73355.305
03:09 ET46785.325
03:12 ET43155.32
03:14 ET22565.32
03:16 ET38655.335
03:18 ET38995.335
03:20 ET36425.33
03:21 ET67785.3463
03:23 ET36245.34
03:25 ET46385.34
03:27 ET9015.35
03:30 ET151875.335
03:32 ET20615.335
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEDIT
Editas Medicine Inc
427.6M
-2.5x
---
United StatesURGN
Urogen Pharma Ltd
480.5M
-3.9x
---
United StatesFATE
Fate Therapeutics Inc
418.9M
-1.9x
---
United StatesYMAB
Y-mAbs Therapeutics Inc
531.0M
-24.5x
---
United StatesADCT
ADC Therapeutics SA
329.9M
-1.2x
---
United StatesALEC
Alector Inc
474.2M
-3.6x
---
As of 2024-06-03

Company Information

Editas Medicine, Inc. is a clinical-stage genome editing company. The Company is focused on developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology. CRISPR uses a protein- ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1), bound to a guide ribonucleic acid (RNA) molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. It is engaged in the development of vivo administered gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body. Its lead program, reni-cel, is an experimental ex vivo gene-edited medicine to treat sickle cell disease (SCD), a severe inherited blood disease that causes premature death, and transfusion-dependent beta thalassemia (TDT).

Contact Information

Headquarters
11 Hurley StCAMBRIDGE, MA, United States 02141-2110
Phone
617-401-9000
Fax
302-655-5049

Executives

Independent Chairman of the Board
Emma Reeve
President, Chief Executive Officer, Director
Gilmore O'Neill
Chief Financial Officer, Executive Vice President
Erick Lucera
Executive Vice President, Chief Scientific Officer
Linda Burkly
Senior Vice President, Chief Medical Officer
Baisong Mei

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$427.6M
Revenue (TTM)
$69.4M
Shares Outstanding
82.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.05
EPS
$-2.10
Book Value
$4.27
P/E Ratio
-2.5x
Price/Sales (TTM)
6.2
Price/Cash Flow (TTM)
---
Operating Margin
-266.85%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.